Shan Pan

887 total citations
30 papers, 671 citations indexed

About

Shan Pan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shan Pan has authored 30 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Shan Pan's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Immune Cell Function and Interaction (5 papers). Shan Pan is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Immune Cell Function and Interaction (5 papers). Shan Pan collaborates with scholars based in China, Hong Kong and Germany. Shan Pan's co-authors include Qiuping Zhang, Jie Xiong, Qian Yin, Muhammad Jamal, R. Xiao, Tian Xie, Liang Shao, Yingjie Wu, Meng Xiong and Zhenbo Tu and has published in prestigious journals such as Cell Metabolism, Cancer Research and Journal of Virology.

In The Last Decade

Shan Pan

30 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shan Pan China	14	421	253	100	95	86	30	671
Mingjing Peng China	14	394 0.9×	195 0.8×	104 1.0×	120 1.3×	70 0.8×	35	659
Tao Ma China	11	434 1.0×	197 0.8×	206 2.1×	85 0.9×	48 0.6×	46	787
Xiuling Li China	16	380 0.9×	198 0.8×	207 2.1×	114 1.2×	120 1.4×	46	788
Hyo Won Chang South Korea	16	477 1.1×	222 0.9×	183 1.8×	64 0.7×	142 1.7×	33	732
Byung-Kyu Ryu South Korea	12	510 1.2×	200 0.8×	210 2.1×	97 1.0×	49 0.6×	14	785
Chang‐Ying Guo China	10	527 1.3×	396 1.6×	155 1.6×	72 0.8×	108 1.3×	23	769
Huashan Liu China	7	458 1.1×	292 1.2×	137 1.4×	180 1.9×	40 0.5×	13	715
Jiasi Zhang China	11	256 0.6×	142 0.6×	59 0.6×	73 0.8×	53 0.6×	26	476
Caroline Contat Switzerland	5	381 0.9×	274 1.1×	169 1.7×	222 2.3×	44 0.5×	5	715

Countries citing papers authored by Shan Pan

Since Specialization

Citations

This map shows the geographic impact of Shan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Pan more than expected).

Fields of papers citing papers by Shan Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Pan. The network helps show where Shan Pan may publish in the future.

Co-authorship network of co-authors of Shan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Pan. A scholar is included among the top collaborators of Shan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Pan. Shan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamal, Muhammad, Xingruo Zeng, Di Xiao, et al.. (2024). Matrin-3 acts as a potential biomarker and promotes hepatocellular carcinoma progression by interacting with cell cycle-regulating genes. Cell Cycle. 23(1). 15–35. 2 indexed citations

Li, Jin, Fei Zheng, Wei Zhou, et al.. (2023). PR064/#206 Multicenter real-world experiences of PARPi rechallenge in patients with ovarian cancer in China. A66.3–A67. 1 indexed citations

Li, Jingyuan, Muhammad Jamal, Tian Xie, et al.. (2021). LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25. Molecular Immunology. 140. 267–275. 12 indexed citations

Jian, Chongshu, Jiajun Fu, Xu Cheng, et al.. (2020). Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. Cell Metabolism. 31(5). 892–908.e11. 133 indexed citations

Pan, Shan, et al.. (2020). <p>ICAM1 Regulates the Development of Gastric Cancer and May Be a Potential Biomarker for the Early Diagnosis and Prognosis of Gastric Cancer</p>. Cancer Management and Research. Volume 12. 1523–1534. 11 indexed citations

Ye, Jiaxiang, et al.. (2020). Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis. Oncology Reports. 43(5). 1451–1466. 25 indexed citations

Pan, Shan, Dechao Niu, Jianping He, et al.. (2019). Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy. Biomaterials Science. 7(5). 1825–1832. 32 indexed citations

Shao, Liang, Shan Pan, Qiuping Zhang, et al.. (2019). An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease. Frontiers in Immunology. 10. 1233–1233. 11 indexed citations

Jamal, Muhammad, Tianbao Song, Bei Chen, et al.. (2019). Recent Progress on Circular RNA Research in Acute Myeloid Leukemia. Frontiers in Oncology. 9. 1108–1108. 58 indexed citations

10.

Yuan, Wen, Songping Xie, Pan Liu, et al.. (2019). Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues. Journal of Visualized Experiments. 1 indexed citations

11.

Pan, Shan, Xinzhou Deng, Lu Zhou, et al.. (2019). Nicotinamide increases the sensitivity of chronic myeloid leukemia cells to doxorubicin via the inhibition of SIRT1. Journal of Cellular Biochemistry. 121(1). 574–586. 10 indexed citations

12.

Yuan, Wen, Songping Xie, Shan Pan, et al.. (2018). Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer. OncoTargets and Therapy. Volume 11. 1683–1695. 22 indexed citations

13.

Xie, Tian, Shan Pan, Hang Zheng, et al.. (2018). PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression. Cancer Cell International. 18(1). 112–112. 47 indexed citations

14.

Pan, Shan, et al.. (2018). Facile Synthesis of Dendritic Mesoporous Silica Nanoparticles for Co-loading of Doxorubicin and Hemoglobin. Journal of Inorganic Materials. 33(10). 1097–1097. 5 indexed citations

15.

Huang, Xiaoxing, Jie Xiong, Xinzhou Deng, et al.. (2017). NHE1 has a notable role in metastasis and drug resistance of T-cell acute lymphoblastic leukemia. Oncology Letters. 14(4). 4256–4262. 12 indexed citations

16.

Tu, Zhenbo, Songping Xie, Meng Xiong, et al.. (2016). CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. International Journal of Oncology. 50(2). 505–514. 32 indexed citations

17.

Li, Xinran, R. Xiao, Ling Hao, et al.. (2016). PEG10 promotes human breast cancer cell proliferation, migration and invasion. International Journal of Oncology. 48(5). 1933–1942. 44 indexed citations

18.

Pan, Shan, et al.. (2009). Tumor Invasion and Metastasis Initiated by mir-106b in Breast Cancer by Targeting BRMS1 and RB.. Cancer Research. 69(24_Supplement). 6157–6157. 12 indexed citations

19.

Xing, Feiyue, Zhe Yu, Jing Liu, et al.. (2008). Anisomycin Inhibits the Behaviors of T cells and the Allogeneic Skin transplantation in mice. Journal of Immunotherapy. 31(9). 858–870. 12 indexed citations

20.

Hu, Shibin, et al.. (1992). Effects of qingkailing on experimental allergic uveitis in rabbits.. PubMed. 8(3). 138–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact